Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.12% is 86% below its 5-year average of 0.88%, near the low end of its 5-year range (0.09%–4.04%).
As of the fiscal period ended Tuesday, June 30, 2026. 52.64% below its 12-month average of 0.25%.
Reported quarterly debt to assets ratio; no daily interpolation. Q4 FY2026 (2026-06-30): 0.12%.
DEBT TO ASSETS RATIO
0.12%
DEBT TO ASSETS RATIO AVG TTM
0.25%
DEBT TO ASSETS RATIO AVG 3Y
0.67%
DEBT TO ASSETS RATIO AVG 5Y
0.88%
DEBT TO ASSETS RATIO AVG 10Y
15.16%
DEBT TO ASSETS RATIO AVG 15Y
14.37%
DEBT TO ASSETS RATIO AVG 20Y
14.47%
CURRENT VS TTM AVG
-52.64%
CURRENT VS 3Y AVG
-82.13%
CURRENT VS 5Y AVG
-86.45%
CURRENT VS 10Y AVG
-99.21%
CURRENT VS 15Y AVG
-99.17%
CURRENT VS 20Y AVG
-99.17%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+32.92%
vs the sector median at left
Neuphoria Therapeutics Inc.
Market Cap
$18.65M
Debt to Assets Ratio
0.12%
TTM Avg
0.25%
3Y Avg
0.67%
5Y Avg
0.88%
Market Cap
$18.30M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$18.15M
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$19.42M
Debt to Assets Ratio
0.08%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$19.77M
Debt to Assets Ratio
0.07%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.84M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.82M
Debt to Assets Ratio
0.53%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | $18.65M | 0.12% | 0.25% | 0.67% | 0.88% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.30M | 0.00% | N/A | N/A | N/A |
| P3 Health Partners Inc. (PIII)vs › | $18.15M | 0.20% | N/A | N/A | N/A |
| Actuate Therapeutics Inc (ACTU)vs › | $19.42M | 0.08% | N/A | N/A | N/A |
| Quantum BioPharma Ltd. (QNTM)vs › | $19.77M | 0.07% | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $17.39M | 0.26% | N/A | N/A | N/A |
| Lipocine Inc. (LPCN)vs › | $17.31M | 0.00% | N/A | N/A | N/A |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.84M | 0.00% | N/A | N/A | N/A |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.82M | 0.53% | N/A | N/A | N/A |
| Palatin Technologies, Inc. (PTN)vs › | $16.74M | 0.03% | N/A | N/A | N/A |
Debt/Assets
0.1%
Debt/Equity
0.00
Current Ratio
27.85
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.12% |
| 2026-03-31 | 0.10% |
| 2025-12-31 | 0.09% |
| 2025-09-30 | 0.43% |
| 2025-06-30 | 0.52% |
| 2025-03-31 | 0.56% |
| 2024-12-31 | 1.10% |
| 2024-09-30 | 1.11% |
| 2024-06-30 | 0.99% |
| 2023-12-31 | 4.04% |
| 2023-09-30 | 1.11% |
| 2023-06-30 | 1.24% |
| 2023-03-31 | 1.24% |
| 2022-12-31 | 1.09% |
| 2022-09-30 | 1.09% |
| 2022-06-30 | 1.06% |
| 2022-03-31 | 1.06% |
| 2021-12-31 | 1.13% |
| 2021-09-30 | 1.13% |
| 2021-06-30 | 1.60% |
| 2021-03-31 | 1.60% |
| 2020-12-31 | 41.88% |
| 2020-09-30 | 32.20% |
| 2020-06-30 | 35.51% |
| 2020-03-31 | 35.51% |
| 2019-12-31 | 31.16% |
| 2019-09-30 | 31.16% |
| 2019-06-30 | 31.87% |
| 2019-03-31 | 34.10% |
| 2018-12-31 | 33.61% |
| 2018-09-30 | 33.61% |
| 2018-06-30 | 33.15% |
| 2018-03-31 | 32.94% |
| 2017-12-31 | 26.79% |
| 2017-09-30 | 26.79% |
| 2017-06-30 | 22.02% |
| 2017-03-31 | 22.02% |
| 2016-12-31 | 27.21% |
| 2016-09-30 | 27.21% |
| 2016-06-30 | 25.35% |
| 2016-03-31 | 23.57% |
| 2015-12-31 | 20.43% |
| 2015-09-30 | 20.43% |
| 2015-06-30 | 21.38% |
| 2015-03-31 | 21.38% |
| 2014-12-31 | 18.87% |
| 2014-09-30 | 18.87% |
| 2014-06-30 | 1.99% |
| 2013-12-31 | 1.96% |
| 2013-06-30 | 2.02% |
| 2012-12-31 | 2.80% |
| 2012-06-30 | 3.78% |
| 2011-12-31 | 3.82% |
| 2011-06-30 | 8.26% |
| 2010-12-31 | 11.52% |
| 2010-06-30 | 10.53% |
| 2009-12-31 | 9.86% |
| 2009-06-30 | 14.94% |
| 2008-12-31 | 16.02% |
| 2008-06-30 | 14.51% |
| 2007-12-31 | 16.54% |
| 2007-06-30 | 14.34% |
| 2006-12-31 | 19.45% |
| 2006-06-30 | 22.22% |
| 2005-12-31 | 20.60% |
| 2005-06-30 | 27.25% |
| 2004-12-31 | 37.63% |
| 2004-06-30 | 33.98% |
| 2003-12-31 | 44.92% |
| 2003-06-30 | 40.44% |
| 2002-06-30 | 32.41% |
| 2001-06-30 | 0.46% |
